Stason Pharmaceuticals, Inc.: Drug Recall
Recall #D-0367-2024 · 02/09/2024
Class III: Low Risk
Recall Details
- Recall Number
- D-0367-2024
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Stason Pharmaceuticals, Inc.
- Status
- Terminated
- Date Initiated
- 02/09/2024
- Location
- Irvine, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 54, 131 bottles
Reason for Recall
Failed Dissolution Specifications: results slightly under spec at at 9-months.
Product Description
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com
Distribution Pattern
USA Nationwide
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.